[go: up one dir, main page]

WO2006016020A3 - Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan - Google Patents

Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan Download PDF

Info

Publication number
WO2006016020A3
WO2006016020A3 PCT/FR2005/001398 FR2005001398W WO2006016020A3 WO 2006016020 A3 WO2006016020 A3 WO 2006016020A3 FR 2005001398 W FR2005001398 W FR 2005001398W WO 2006016020 A3 WO2006016020 A3 WO 2006016020A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymer
nanoparticles
active principle
bisulfan
optionally
Prior art date
Application number
PCT/FR2005/001398
Other languages
English (en)
Other versions
WO2006016020A2 (fr
Inventor
Anne Magali Layre
Ruxandra Gref
Patrick Couvreur
Joel Richard
Original Assignee
Ethypharm Sa
Anne Magali Layre
Ruxandra Gref
Patrick Couvreur
Joel Richard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa, Anne Magali Layre, Ruxandra Gref, Patrick Couvreur, Joel Richard filed Critical Ethypharm Sa
Publication of WO2006016020A2 publication Critical patent/WO2006016020A2/fr
Publication of WO2006016020A3 publication Critical patent/WO2006016020A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

La présente invention se rapporte à des nanoparticules polymériques composites biodégradables, pouvant contenir éventuellement un principe actif, ainsi qu'à des suspensions en milieu aqueux de telles particules, leur préparation et leur utilisation.
PCT/FR2005/001398 2004-07-07 2005-06-07 Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan WO2006016020A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0407569 2004-07-07
FR0407569A FR2872703B1 (fr) 2004-07-07 2004-07-07 Nanoparticules polymeriques composites

Publications (2)

Publication Number Publication Date
WO2006016020A2 WO2006016020A2 (fr) 2006-02-16
WO2006016020A3 true WO2006016020A3 (fr) 2006-07-13

Family

ID=34946547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/001398 WO2006016020A2 (fr) 2004-07-07 2005-06-07 Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan

Country Status (2)

Country Link
FR (1) FR2872703B1 (fr)
WO (1) WO2006016020A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090122479A (ko) * 2007-03-30 2009-11-30 에이전시 포 사이언스, 테크놀로지 앤드 리서치 소수성 양자점의 캡슐화
MX360638B (es) 2011-04-28 2018-11-12 Univ Texas Formulaciones parenterales mejoradas de agentes farmacéuticos lipofílicos y métodos para prepararlos y usarlos.
WO2014191502A1 (fr) 2013-05-28 2014-12-04 Sinvent As Procédé de préparation de nanoparticules furtives
CN108453927A (zh) * 2018-02-08 2018-08-28 西安交通大学 一种可生物降解PCL/Mg复合材料FDM耗材的制备工艺
EP3773471A1 (fr) * 2018-03-27 2021-02-17 Sintef Tto As Nanoparticules de poly (cyanoacrylate d'alkyle) destinées à être utilisées dans le traitement du cancer
US12433846B2 (en) 2019-03-27 2025-10-07 Sintef Tto As Drug delivery system for treatment of cancer

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007895A1 (fr) * 1978-07-19 1980-02-06 Patrick Couvreur Nanoparticules biodégradables, compositions pharmaceutiques les contenant et procédé pour leur préparation
FR2608942A1 (fr) * 1986-12-31 1988-07-01 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
EP0447318A1 (fr) * 1990-03-16 1991-09-18 L'oreal Composition pour le traitement cosmétique et/ou pharmaceutique des couches supérieures de l'épiderme par application topique sur la peau et procédé de préparation correspondant
WO1996031231A1 (fr) * 1995-04-04 1996-10-10 Elan Corporation, Plc Nanoparticules biodegradables a liberation lente renfermant de l'insuline
WO1999043359A1 (fr) * 1998-02-27 1999-09-02 Bioalliance Pharma (S.A.) Nanoparticules comprenant polyisobutylcyanoacrylate et cyclodextrines
WO2003017987A1 (fr) * 2001-08-31 2003-03-06 Mcgill University Nanocapsules polymeres biodegradables et utilisation de celles-ci
CN1417242A (zh) * 2002-11-14 2003-05-14 天津大学 聚乙二醇接枝修饰的聚氰基丙烯酸酯共聚物及其制备方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007895A1 (fr) * 1978-07-19 1980-02-06 Patrick Couvreur Nanoparticules biodégradables, compositions pharmaceutiques les contenant et procédé pour leur préparation
FR2608942A1 (fr) * 1986-12-31 1988-07-01 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
EP0447318A1 (fr) * 1990-03-16 1991-09-18 L'oreal Composition pour le traitement cosmétique et/ou pharmaceutique des couches supérieures de l'épiderme par application topique sur la peau et procédé de préparation correspondant
WO1996031231A1 (fr) * 1995-04-04 1996-10-10 Elan Corporation, Plc Nanoparticules biodegradables a liberation lente renfermant de l'insuline
WO1999043359A1 (fr) * 1998-02-27 1999-09-02 Bioalliance Pharma (S.A.) Nanoparticules comprenant polyisobutylcyanoacrylate et cyclodextrines
WO2003017987A1 (fr) * 2001-08-31 2003-03-06 Mcgill University Nanocapsules polymeres biodegradables et utilisation de celles-ci
CN1417242A (zh) * 2002-11-14 2003-05-14 天津大学 聚乙二醇接枝修饰的聚氰基丙烯酸酯共聚物及其制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 200370, Derwent World Patents Index; Class A14, AN 2003-732339, XP002317291 *
HASSAN M ET AL: "A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem transplantation: 500 mg/m<2> as a optimal total dose for conditioning", BONE MARROW TRANSPLANTATION 2002 UNITED KINGDOM, vol. 30, no. 12, 2002, pages 833 - 841, XP002367646, ISSN: 0268-3369 *

Also Published As

Publication number Publication date
WO2006016020A2 (fr) 2006-02-16
FR2872703B1 (fr) 2006-10-06
FR2872703A1 (fr) 2006-01-13

Similar Documents

Publication Publication Date Title
WO2007062266A3 (fr) Formes galeniques de ganaxolone et procedes de preparation et d&#39;utilisation de celles-ci
Ge et al. Core-satellite nanocomposite catalysts protected by a porous silica shell: controllable reactivity, high stability, and magnetic recyclability
WO2009001697A3 (fr) Microsphères ayant une structure noyau/enveloppe
PL1879936T3 (pl) Wodne, stabilne podczas przechowywania emulsje polimerów zakończonych alfa-sililem, ich wytwarzanie i zastosowanie
WO2010077628A3 (fr) Composition d&#39;hygiène personnelle sous la forme d&#39;un article à structure solide soluble et poreuse
EP4360756A3 (fr) Matières actives de batterie nanostructurées et leurs procédés de production
WO2008007290A3 (fr) nanoparticules à noyau/enveloppe à des fins de thérapie et d&#39;imagerie
WO2007130237A3 (fr) Compositions contenant des tensioactifs polymérisés à faible degré de polymérisation et procédés d&#39;utilisation de ceux-ci
WO2005084637A3 (fr) Nouveaux procedes et nouvelle composition d&#39;administration de macromolecules par voie orale
IL190775A (en) Influenza virus-like particles, vaccines containing them and their uses
EP2368581A3 (fr) Particules d&#39;embolisation intravasculaire poreuses et procédés apparentés
AU2006282042A8 (en) Nanoparticle fabrication methods, systems, and materials
WO2007076990A3 (fr) Particules d&#39;agglomerat, procede de production de nanocomposites et leur utilisation
AU2002361032A1 (en) Nanoscale core/shell particles and the production thereof
WO2010002613A3 (fr) Procédé de fabrication d’une composition pharmaceutique en poudre sèche
WO2007120193A3 (fr) Nanobiomatieres et leur synthese
WO2005094156A3 (fr) Oxydes metalliques a modification de surface, procedes de production desdits oxydes metalliques et leur utilisation dans des preparations cosmetiques
EP1640811A3 (fr) Révélateur
WO2005089297A3 (fr) Coussin a geometrie variable a auto ventilation et a auto refroidissement
WO2006105234A3 (fr) Nanoparticules inorganiques hybrides, leurs procedes d&#39;utilisation et de production
WO2006016020A3 (fr) Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan
WO2007102929A3 (fr) Synthèse et utilisation de sphères creuses hydrophiles réticulées pour l&#39;encapsulation de cargaison hydrophile
WO2008073731A3 (fr) Formes galéniques de microémulsion de valsartan et procédés de préparation de celles-ci
WO2007025994A3 (fr) Utilisation d&#39;au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
JP2009161439A5 (fr)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application